| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/19/2007 | EP1865944A2 Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people |
| 12/19/2007 | EP1865938A2 Dosing regimes for trans-clomiphene |
| 12/19/2007 | EP1865778A2 Methods for avoiding edema in the treatment of metabolic, inflammatory, and cardiovascular disorders |
| 12/19/2007 | EP1781656B1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 12/19/2007 | EP1771426B1 Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1b (ptp1b) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1434567B1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 12/19/2007 | EP1422224B1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 12/19/2007 | EP1420802B1 Increased solubility flavanolignan preparations |
| 12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/19/2007 | EP1353694B1 Combinations of ezetimibe with aspirine for treating vascular conditions |
| 12/19/2007 | EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 12/19/2007 | EP1230369B1 Polypeptide hormone phosphatonin |
| 12/19/2007 | EP1229927B1 Use of a growth hormone or a growth hormone secretagogue for appetite-suppression or induction of satiety |
| 12/19/2007 | EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 12/19/2007 | CN101090885A Lactams as comformationally constrained peptidomimetic inhibitors |
| 12/19/2007 | CN101090732A Method for treating diabetes |
| 12/19/2007 | CN101090724A Heterocyclic derivatives and their use as therapeutic agents |
| 12/19/2007 | CN101090717A Methods for regulating weight and size of animals |
| 12/19/2007 | CN101089170A Health ginseng-wolfberry fruit wine for diabetics |
| 12/19/2007 | CN101088982A Fenofibrate derivative containing nitric ester and its medicinal use |
| 12/19/2007 | CN101088521A Astragalus medicine prepn and its prepn process |
| 12/19/2007 | CN101088518A Medicine prepn for reducing blood sugar and regulating blood pressure |
| 12/19/2007 | CN101088501A Prepn process of germanium containing nutrient solution |
| 12/19/2007 | CN101088487A Cosmetic or pharmaceutical composition comprising a condensation polymer, cosmetic treatment method employing said composition, said condensation polymer and preparation method |
| 12/19/2007 | CN101088403A Health food for slimming and eliminating distension and its production process |
| 12/19/2007 | CN101088401A Concentrated liquid and its prepn process |
| 12/19/2007 | CN101088371A Instant colorful noodles |
| 12/19/2007 | CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds |
| 12/19/2007 | CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 12/19/2007 | CN100355728C Inhibitors of dipeptidyl peptidase IV |
| 12/19/2007 | CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity |
| 12/19/2007 | CN100355440C Compound Chinese medicinal preparation for treating type II diabetes and lowering blood sugar and its preparation method |
| 12/19/2007 | CN100355434C Medicine for preventing and treating cardiovascular and cerebrovascular diseases |
| 12/19/2007 | CN100355424C Extractive of 'Zong'wood for treating diabetes, and application of saponin of 'Zong' wood for treating diabetes |
| 12/19/2007 | CN100355421C Use of docosahexanoic acid as active substance for the treatment of lipodystrophy |
| 12/19/2007 | CN100355420C Leucine-enriched nutritional compositions |
| 12/19/2007 | CN100355415C Frozen dry powder injection of astrogalus root and its preparing method |
| 12/19/2007 | CA2602273A1 Composition and method for weight loss |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309720 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders |
| 12/18/2007 | US7309704 Piperidinyl- and pyrimidinyl-ureas: N-(1-acetyl-4-piperidinyl)-N-methyl-N'-(5-(3,5-difluorophenyl)-2-pyrimidinyl)urea; metabolic disorders, eating disorders, disorders associated with obesity: type II diabetes, insulin resistance, hyperlipidemia or hypertension. |
| 12/18/2007 | US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 12/18/2007 | CA2602189A1 Fat .beta.-oxidation enhancing and carbohydrate absorption inhibition |
| 12/18/2007 | CA2489763C Pharmaceutical salts of reboxetine |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2235400C Cartilage/bone inducing materials for reparation |
| 12/13/2007 | WO2007143336A2 Use of ractopamine enantiomers |
| 12/13/2007 | WO2007143002A2 Nutraceutical treatments for diabetic and non-diabetic wound healing |
| 12/13/2007 | WO2007142581A1 Combination product for the treatment or prevention of dyslipidaemia |
| 12/13/2007 | WO2007142369A1 Method for screening of anti-obesity agent |
| 12/13/2007 | WO2007142306A1 Highly water-soluble agave inulin, agave inulin-containing product, agave inulin-origin product and by product and method of producing the same |
| 12/13/2007 | WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 12/13/2007 | WO2007142297A1 Composition for prevention/treatment of hepatic disease |
| 12/13/2007 | WO2007142286A1 Fatigue-reducing agent |
| 12/13/2007 | WO2007142253A1 2-cyanopyrrolidine derivative |
| 12/13/2007 | WO2007142231A1 Agent for improvement in blood fluidity |
| 12/13/2007 | WO2007142230A1 Lipid-metabolism-improving agent |
| 12/13/2007 | WO2007142217A1 1-phenylpyridone derivative |
| 12/13/2007 | WO2007142118A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 12/13/2007 | WO2007141538A1 Oxazole derivatives and their use in the treatment of diabetes and obesity |
| 12/13/2007 | WO2007141517A1 Benzimidazoles and their use for the treatemnt of diabetes |
| 12/13/2007 | WO2007141504A1 Fused thiophene derivatives as kinase inhibitors |
| 12/13/2007 | WO2007141502A1 Chemical compounds |
| 12/13/2007 | WO2007141423A1 Ppar enhancing derivatives, method for preparing same and therapeutic use thereof |
| 12/13/2007 | WO2007141200A1 Novel n-aryl and n-heteroaryl substituted pyridinone derivatives for use in mch-1 mediated diseases |
| 12/13/2007 | WO2007141026A1 Use of a polyphenol in the treatment of the metabolic syndrome and endothelial dysfunction or other vascular sequellae. |
| 12/13/2007 | WO2007140619A1 Derivatized insulin oligomers |
| 12/13/2007 | WO2007140590A1 Methods and compositions for inducing bone synthesis |
| 12/13/2007 | WO2007127763A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 12/13/2007 | WO2007121546A8 Use of mas-g-protein-coupled receptor agonists in the treatment of the metabolic syndrome, its components and its complications |
| 12/13/2007 | WO2007110730A3 Varenicline standards and impurity controls |
| 12/13/2007 | WO2007105171A3 Killing of selected cells |
| 12/13/2007 | WO2007103776A3 A2a adenosine receptor antagonists |
| 12/13/2007 | WO2007098106A3 Respiratory tract delivery of interferon-tau |
| 12/13/2007 | WO2007095616A3 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 12/13/2007 | WO2007070506A3 Diaza heterocyclic sulfonamide derivatives and their uses |
| 12/13/2007 | WO2006079720A8 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 12/13/2007 | WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
| 12/13/2007 | US20070287970 Method for systemic drug delivery through the nail |
| 12/13/2007 | US20070287728 Novel Naphthyl Substituted Azabicyclo Derivatives and Their Use as Monomine Neurotransmitter Re-Uptake Inhibitors |
| 12/13/2007 | US20070287721 Pyrazolopyridinyl pyridine |
| 12/13/2007 | US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 12/13/2007 | US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent |
| 12/13/2007 | US20070287706 Certain substituted quinolones, compositions, and uses thereof |
| 12/13/2007 | US20070287705 Crf Receptor Antagonists and Methods Relating Thereto |
| 12/13/2007 | US20070287693 Benzamide Derivatives That Act Upon The Glucokinase Enzyme |
| 12/13/2007 | US20070287691 Administering diacylglycerol as an antidiabetic agent to lower the homeostasis model assessment index ratio (HOMA-R); accumulation of fatty acids in the small intestine to promote beta-oxidation; prevent triglyceride formation; lower blood remnant-like lipoproteins/leptin levels; cardiovascular diorders |
| 12/13/2007 | US20070287674 New treatment of diabetes mellitus |
| 12/13/2007 | US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070286886 Materials And Methods For Inducing Apoptosis In Adipocytes |
| 12/13/2007 | US20070286863 CMKLR regulation of adipogenesis and adipocyte metabolic function |
| 12/13/2007 | US20070286857 Anti-Cd52 Antibody Treatment for Diabetes |
| 12/13/2007 | US20070286854 Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1) |
| 12/13/2007 | US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard) |
| 12/13/2007 | US20070286841 Method for lowering serum glucose |
| 12/13/2007 | US20070286805 Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof |